Primary FDA-Approved Indications
Widely used for motion sickness and vestibular nausea in pediatrics.
Motion sickness prophylaxis
FDA ApprovedChildren and adolescentsClinical studies
Vestibular nausea
FDA ApprovedChildrenClinical experience
Evidence-based guide for pediatric prescribing
Dimenhydrinate targets vestibular-mediated nausea.
Widely used for motion sickness and vestibular nausea in pediatrics.